Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by deepoil0808on Nov 15, 2021 8:25pm
273 Views
Post# 34129781

Reviewed financials - Several concerns with the numbers

Reviewed financials - Several concerns with the numbersI have reviewed the financial statements of the company and once I passed the headlines I found several areas of concern as follows:

Sales of $ 25 million and receivables of $ 24 million

How can the company have $ 25 million in sales and, $ 24 million in receivables?   This means that they only collected $ 1 million from these sales?   Am I reading this correctly?

Accounts payable of +/- $ 20,500,000

How can the company have accounts payable of $ 20,500,000?   Accounts payable are paid within 30 days.

Are the employees working for free for 3 months?

I did not see any details on sedar as to why these amounts are so huge

Impairement of +/- $ 1,700,000

There is another impairement of $ 1,700,000, which seems to confirm another lost investment.  So add this to the mountain of other bad investments.

Cash of only +/- $ 900,000

I would like to know where all the cash went from the private placements.   It was to clear the debts.   Long term debts goes down but short term debt of accounts payable skyrockets upwards?   

With payables soaring it means very few people are getting paid, so with raising of funds, where did funds go to?


Reverse stock split 1 for 15

There would be no need to do a reverse stock split with numbers reported so why are they still doing it?

Covid19 virus going away

Per Pfizer spokesman, pandemic going away on January 4th, 2022.    David wants to continue testing as he sees the pandemic here to stay.    Right now I would side with Pfizer as there were only +/- 148 deaths in USA yesterday, a huge low.

Good Luck to Everyone,

Definitely happy that I sold and, will not buy at all.    Too many concerns

My personal opinion

<< Previous
Bullboard Posts
Next >>